切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 286 -290. doi: 10.3877/cma.j.issn.1674-3903.2021.05.006

经验交流

肾移植后人类细小病毒B19和BK病毒双重感染一例并文献复习
高霞1, 陈显凌2, 付军明1, 吴卫真1, 杨顺良1,()   
  1. 1. 350025 福州,中国人民解放军联勤保障部队第九〇〇医院泌尿外科
    2. 350001 福州,福建医科大学附属协和医院血液科
  • 收稿日期:2021-07-22 出版日期:2021-10-25
  • 通信作者: 杨顺良
  • 基金资助:
    福建省科技厅引导性项目(2015Y5007)

Diagnosis and therapy for dual infection of human parvovirus B19 and BK virus after renal transplantation and review of the literature

Xia Gao1, Xianling Chen2, Junming Fu1, Weizhen Wu1, Shunliang Yang1,()   

  1. 1. Department of Urology, 900th Hospital of Joint Logistics Support Force, Fuzhou 350025, China
    2. Department of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China
  • Received:2021-07-22 Published:2021-10-25
  • Corresponding author: Shunliang Yang
引用本文:

高霞, 陈显凌, 付军明, 吴卫真, 杨顺良. 肾移植后人类细小病毒B19和BK病毒双重感染一例并文献复习[J/OL]. 中华移植杂志(电子版), 2021, 15(05): 286-290.

Xia Gao, Xianling Chen, Junming Fu, Weizhen Wu, Shunliang Yang. Diagnosis and therapy for dual infection of human parvovirus B19 and BK virus after renal transplantation and review of the literature[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(05): 286-290.

图1 肾移植后HPV-B19和BKV双重感染受者IVIG治疗前后血红蛋白、肾功能与病毒载量动态变化情况注:HPV-B19.人类细小病毒B19; BKV.BK病毒;IVIG.静脉注射免疫球蛋白
表1 文献检索的HPV-B19感染肾移植受者临床资料[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19]
项目 HPV-B19合并BKV感染组(n=11) 单纯HPV-B19感染组(n=129) HPV-B19感染病例(n=158)
性别(例,男/女/不详) 0/2/9 54/37/38 90/66/2
发病年龄(岁) 29~76 9~65 6~76
供肾类型(例,活体/尸体/不详) 0/3/8 41/38/50 79/65/14
多次移植(例,是/否/不详) 1/3/7 9/73/47 13/128/17
DGF(例,是/否/不详) 1/3/7 4/66/59 10/114/34
ATG或CD3单克隆抗体应用(例,是/否/不详) 2/1/8 16/37/76 24/46/88
CD25单克隆抗体应用(例,是/否/不详) 0/3/8 13/40/76 18/52/88
他克莫司(例,是/否/不详) 3/1/7 60/31/38 98/52/8
霉酚酸类药物(例,是/否/不详) 3/1/7 61/29/39 98/51/9
移植至HPV-B19感染发病时间(月) 0.5~ 3.0 0~98.0 0~98.0
最低血红蛋白(g/L) 65~81 26~89 24~90
白细胞减少(例,是/否/不详) 1/2/8 27/45/57 36/54/68
血小板减少(例,是/否/不详) 0/1/10 10/55/64 15/67/76
感染前发生排斥反应(例,是/否/不详) 2/1/8 19/46/64 43/86/29
应用IVIG(例,是/否/不详) 4/0/7 83/9/37 129/21/8
他克莫司转换为环孢素(例,是/否/不详) 0/2/9 14/55/60 21/73/64
停用抗代谢药物(例,是/否/不详) 0/3/8 32/39/58 38/50/70
降低免疫抑制强度(例,是/否/不详) 3/1/7 66/17/46 84/19/55
治疗后发生排斥反应(例,是/否/不详) 2/1/8 2/56/71 22/90/46
血红蛋白恢复(例,是/否/不详) 10/0/1 82/11/36 135/14/9
肾功能损伤(例,是/否/不详) 1/1/9 29/49/51 44/58/56
肾功能恢复(例,是/否/不详) 1/0/0 20/5/4 27/7/10
HPV-B19清除(例,是/否/不详) 2/1/8 38/17/74 49/22/87
移植术后HPV-B19感染复发(例,是/否/不详) 0/3/8 25/54/50 30/76/52
复发次数(次) - 1~ 9 1~ 9
复发时间(月) - 0.3~29.0 0.3~29.0
1
Nowacka-Cieciura E, Karakulska-Prystupiuk E, Żuk-Wasek A, et al. Pure red cell aplasia related to parvovirus B19 infection in simultaneous pancreas and kidney recipient: A case report[J]. Transplant Proc, 2020, 52(8): 2539-2543.
2
Labbadia F, Salido-Fierréz E, Majado-Martinez J, et al. Pure red cell aplasia in a simultaneous pancreas-kidney transplantation patient: inside the erythroblast[J]. Hematol Rep, 2012, 4(3): e17.
3
Sharma N, Bajwa R. Parvovirus infection-related anemia after kidney transplantation[J]. Case Rep Transplant, 2020, 2020: 6437392.
4
Knysak M, Napora M, Misiukiewicz-Poć M, et al. Pure red cell aplasia and antibody-mediated rejection: double trouble in 1 kidney transplant recipient solved by intravenous immunoglobulin infusion: A case report[J]. Transplant Proc, 2020, 52(8): 2530-2532.
5
Hai An HP, Diem HT, Cuong NT. Parvovirus B19-associated anemia in kidney transplant recipients: A single-center experience[J]. Transplant Proc, 2019, 51(8): 2693-2696.
6
Baek CH, Kim H, Yang WS, et al. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients[J]. Transpl Infect Dis, 2017, 19(5): e12754.
7
Tsinalis D, Dickenmann M, Brunner F, et al. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin[J]. Am J Kidney Dis, 2002, 40(3): 667-670.
8
Oramas DM, Setty S, Yeldandi V, et al. A case report of parvovirus B19 infection in a renal allograft[J]. Int J Surg Pathol, 2017, 25(7): 648-651.
9
Pinto V, Grandy J, Zambrano P, et al. Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports[J]. Transplant Proc, 2008, 40(9): 3261-3264.
10
Becker MR, Schneider B, Reber U, et al. Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients[J]. Transplant Proc, 2005, 37(10): 4306-4308.
11
Lui SL, Luk WK, Cheung CY, et al. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit[J]. Transplantation, 2001, 71(1): 59-64.
12
Marchand S, Tchernia G, Hiesse C, et al. Human parvovirus B19 infection in organ transplant recipients[J]. Clin Transplant, 1999, 13(1 Pt 1): 17-24.
13
Keung YK, Chuahirun T, Wesson D. Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation[J]. Nephrol Dial Transplant, 1999, 14(2): 469-471.
14
Moudgil A, Shidban H, Nast CC, et al. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin[J]. Transplantation, 1997, 64(12): 1847-1850.
15
Sturm I, Watschinger B, Geissler K, et al. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient[J]. Nephrol Dial Transplant, 1996, 11(7): 1367-1370.
16
Mascia G, Argiolas D, Carta E, et al. Successful treatment of anemia with anaplastic and microangiopathic characteristics in a kidney transplant recipient with parvovirus B19 infection: A case report[J]. Transplant Proc, 2020, 52(5): 1619-1622.
17
Murdock J, Morris TC, Alexander HD, et al. Red cell aplasia due to erythrovirus parvovirus B19 infection in a Jehovah′s witness with post-transplant EBV-induced aggressive lymphoma: management considerations[J]. Leuk Lymphoma, 2002, 43(1): 211-213.
18
al-Khaldi N, Watson AR, Harris A, et al. Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient[J]. Pediatr Nephrol, 1994, 8(3): 349-350.
19
Krishnan P, Ramadas P, Rajendran PP, et al. Effects of parvovirus B19 infection in renal transplant recipients: A retrospective review of three cases[J]. Int J Angiol, 2015, 24(2): 87-92.
20
Eid AJ, Ardura MI; AST Infectious Diseases Community of Practice, AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice[J]. Clin Transplant, 2019, 33(9): e13535.
21
Sharma R, Zachariah M. BK virus nephropathy: Prevalence, impact and management strategies[J]. Int J Nephrol Renovasc Dis, 2020, 13: 187-192.
22
Sharma R, Tzetzo S, Patel S, et al. BK virus in kidney transplant: Current concepts, recent advances, and future directions[J]. Exp Clin Transplant, 2016, 14(4): 377-384.
23
Park JB, Kim DJ, Woo SY, et al. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study[J]. Transpl Int, 2009, 22(4): 455-462.
24
Carraturo A, Catalani V, Ottaviani D, et al. Parvovirus B19 infection and severe anemia in renal transplant recipients[J]. ScientificWorldJournal, 2012, 2012: 102829.
25
Inamdar N, Nada R, Minz R, et al. Successful re-transplantation in patient with recurrent parvovirus B19 pure red cell aplasia[J]. Transpl Infect Dis, 2019, 21(6): e13164.
26
Ardalan MR, Shoja MM, Tubbs RS, et al. Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis[J]. Exp Clin Transplant, 2008, 6(2): 137-143.
27
Eid AJ, Brown RA, Patel R, et al. Parvovirus B19 infection after transplantation: a review of 98 cases[J]. Clin Infect Dis, 2006, 43(1): 40-48.
28
黄森林,于立新,邓文锋,等. 肾移植术后人类微小病毒B19感染致纯红细胞再生障碍性贫血2例并文献复习[J]. 器官移植2015, 6(4): 249-253.
29
Barzon L, Murer L, Pacenti M, et al. Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury[J]. J Infect Dis, 2009, 199(3): 372-380.
30
Means RT Jr. Pure red cell aplasia[J]. Blood, 2016, 128(21): 2504-2509.
31
Chen XT, Li J, Deng RH, et al. The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy[J]. Biosci Rep, 2019, 39(2): BSR20182058.
[1] 中华医学会器官移植学分会. 遗体捐献肾脏获取手术技术操作指南[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 257-265.
[2] 邹永康, 石雍, 徐贤刚, 张帅民, 刘衍, 杨生鹏, 叶啟发, 陈根, 张毅. 肾移植术后手术切口米根霉感染伴菌血症一例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 289-292.
[3] 吕玥彤, 靳梦圆, 周大为, 叶啟发. 机器人辅助下肾移植的临床进展与争议[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 242-246.
[4] 尚丽红, 王志华, 张文艳, 朱琳茹, 周华. 内皮粘蛋白抗体与肾移植术后抗体介导排斥反应和移植肾预后的研究[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 165-170.
[5] 吕军好, 林锦雯, 张心怡, 陈江华. 细胞外囊泡在肾移植诊断和治疗中的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 186-192.
[6] 陆婷, 陈浩, 王雪静, 谭若芸, 彭宇竹. 肾移植术后一年发生代谢综合征的危险因素分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 98-103.
[7] 郭明星, 徐烨, 徐菀佚, 赵莹, 刘冉佳, 潘晨, 崔向丽. 2017—2022年中国105家医院肾移植术后门诊受者免疫抑制剂用药分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 104-109.
[8] 张心怡, 吕军好, 陈大进. 2023年肾移植领域研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 7-11.
[9] 吴小山, 任桂灵, 朱杰东, 史天陆, 马葵芬. 肾移植受者围手术期霉酚酸暴露量及不良反应分析[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 17-21.
[10] 赵丽, 蔡瑞明, 赵纪强, 林民专, 陈志勇, 彭娟. 肾移植术后新发泌尿系统恶性肿瘤二例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 35-39.
[11] 陆婷, 姜巧玲, 孙黎, 王雪静. 加速康复外科在肾移植围手术期应用的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 55-59.
[12] 刘路浩, 张鹏, 陈荣鑫, 郭予和, 尹威, 徐璐, 李光辉, 方佳丽, 马俊杰, 陈正. 奈玛特韦/利托那韦治疗肾移植术后重型新型冠状病毒肺炎的临床效果分析[J/OL]. 中华移植杂志(电子版), 2023, 17(06): 349-353.
[13] 李晓宇, 许昕, 谌诚, 张萌, 韩文科, 林健. 肾移植受者新型冠状病毒感染合并肺炎支原体感染临床特点及诊疗分析[J/OL]. 中华移植杂志(电子版), 2023, 17(06): 354-357.
[14] 彭雨诗, 苗芸, 严紫嫣. 宏基因组高通量测序诊断肾移植术后华支睾吸虫感染一例[J/OL]. 中华移植杂志(电子版), 2023, 17(05): 297-299.
[15] 张秋玥, 程羽, 牛雨田, 唐茂芝, 张克勤, 张懿, 郭亚楠, 涂增. 肾移植与人体微生态的相关性研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 207-213.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?